| Financial Services Industry | Financials Sector | Mr. Mohammad Bin Saleh Bin Mohammad Al Hammadi CEO | XSAU Exchange | SA13J051UJH4 ISIN |
| Saudi Arabia Country | 3,245 Employees | 16 Aug 2026 Last Dividend | 16 Apr 2015 Last Split | - IPO Date |
Al Hammadi Holding Company, originally known as Al Hammadi Company For Development and Investment, is a premier healthcare organization based in Riyadh, Saudi Arabia. Since its inception in 1985, the group has been at the forefront of providing comprehensive medical services across the Kingdom of Saudi Arabia. In August 2022, it underwent a strategic rebranding to become Al Hammadi Holding Company, reflecting its broadened scope and commitment to health and pharmaceutical services. Operating primarily through two segments, Medical Services and Pharmaceutical Products, Al Hammadi Holding Company has cemented its position as a cornerstone of the Saudi healthcare industry.
At the core of Al Hammadi Holding Company's offerings lies its medical services. Catering to a wide range of healthcare needs, the company provides advanced medical treatments and healthcare solutions. This encompasses general healthcare services, specialized procedures, and comprehensive patient care, facilitated by a team of seasoned medical professionals and state-of-the-art medical facilities.
Complementing its medical services, Al Hammadi Holding Company is also engaged in the sale of pharmaceutical products. This segment ensures the provision of high-quality, effective medicines and healthcare products to patients and healthcare facilities across Saudi Arabia. It underscores the company’s commitment to not only treating but also preventing health issues by offering a wide range of pharmaceutical solutions that cater to various medical needs.